2009-2010 Session
Change SessionS.48 (Act 59)
An act relating to the marketing of prescribed products
Sen. Peter Shumlin , Sen. Kevin Mullin , Sen. Matthew Choate
,
Sen. Timothy Ashe , Sen. Claire Ayer , Sen. Susan Bartlett , Sen. Randolph Brock III, Sen. John Campbell , Sen. William Carris , Sen. Ann Cummings , Sen. William Doyle , Sen. Edward Flanagan , Sen. Harold Giard , Sen. Robert Hartwell , Sen. Vincent Illuzzi , Sen. M. Jane Kitchel , Sen. Sara Kittell , Sen. Virginia Lyons , Sen. Mark MacDonald , Sen. Richard Mazza , Sen. Richard McCormack , Sen. Hinda Miller , Sen. Alice Nitka , Sen. Douglas Racine , Sen. Philip Scott , Sen. Richard Sears Jr., Sen. Diane Snelling , Sen. Robert Starr , Sen. Jeanette White
5/9/2009 - Signed by Governor on June 8, 2009
- Sponsor(s)
-
- Sen. Peter Shumlin
- Sen. Kevin Mullin
- Sen. Matthew Choate
- Additional Sponsors
- Sen. Timothy Ashe
- Sen. Claire Ayer
- Sen. Susan Bartlett
- Sen. Randolph Brock III
- Sen. John Campbell
- Sen. William Carris
- Sen. Ann Cummings
- Sen. William Doyle
- Sen. Edward Flanagan
- Sen. Harold Giard
- Sen. Robert Hartwell
- Sen. Vincent Illuzzi
- Sen. M. Jane Kitchel
- Sen. Sara Kittell
- Sen. Virginia Lyons
- Sen. Mark MacDonald
- Sen. Richard Mazza
- Sen. Richard McCormack
- Sen. Hinda Miller
- Sen. Alice Nitka
- Sen. Douglas Racine
- Sen. Philip Scott
- Sen. Richard Sears Jr.
- Sen. Diane Snelling
- Sen. Robert Starr
- Sen. Jeanette White
- Less…
- Last Recorded Action
- Senate 5/9/2009 - Signed by Governor on June 8, 2009
Bill/Resolution Text
- Other Text
-
NOTE: to print information that appears on a tab within the bill page, use the Print link on that tab.
An act relating to the marketing of prescribed products
Detailed Status
2009 - 2010 Legislative Session
| Body | Date | Journal | Calendar | Location | Full Status |
|---|
An act relating to the marketing of prescribed products
Roll Call History
2009 - 2010 Legislative Session
| Body | Date | Journal | Location | Full Status |
|---|
Although procedurally bills and resolutions are assigned to only one committee at a time, other committees may review the bill or resolution. This page contains results from both the assigned committee as well as other committees.
An act relating to the marketing of prescribed products
Committee Meetings
2009 - 2010 Legislative Session
| Meeting Date | Committee |
|---|
An act relating to the marketing of prescribed products
Meeting Full List
2009 - 2010 Legislative Session
Friday, January 30, 2009
- Committee(s):
- Senate Committee on Finance
- 1:30 PM
-
S.48 - An act relating to the marketing of prescribed products
Review bill with staff
Robin Lunge, Legislative Counsel
Jennifer Carbee, Legislative Counsel
Tuesday, February 3, 2009
- Committee(s):
- Senate Committee on Finance
- 3:15 p.m.
-
S.48 - An act relating to the marketing of prescribed products
Testimony from interested parties
Wendy Morgan, Assistant Attorney General, Attorney General's Office
Bridget Asay, Assistant Attorney General, Attorney General's Office
Paul Harrington, Executive Vice President, Vermont Medical Society
Ken Libertoff, Director, Vermont Association for Mental Health
Wednesday, February 4, 2009
- Committee(s):
- Senate Committee on Finance
- 3:00 p.m.
-
S.48 - An act relating to the marketing of prescribed products
Ann Rugg, Deputy Director, Office of Vermont Health Access, Agency of Human Services
Elaine Erenrich Rosenburg, Director, Asthma and Allergy Foundation of America/New England Chapter
Jennifer Carbee, Legislative Counsel
Robin Lunge, Legislative Counsel
Sen. Peter Shumlin, Senate President Pro Tempore, Windham County
Chip Morgan, Assistant Attorney General, Attorney General's Office
Thursday, February 5, 2009
- Committee(s):
- Senate Committee on Finance
- 3:15 p.m.
-
S.48 - An act relating to the marketing of prescribed products
Testimony via telephone
Sharon Treat, Director, National Legislative Association on Prescription Drug Prices
- 3:45 p.m.
-
S.48 - An act relating to the marketing of prescribed products
Philene Taormina, Director of Advocacy, AARP
Tom Simpatico, MD, President, Vermont Psychiatric Association
Ken Libertoff, Director, Vermont Association for Mental Health
- 4:30 p.m.
-
S.48 - An act relating to the marketing of prescribed products
Testimony via telephone
John R Brumsted, MD, Chief Quality Officer, Fletcher Allen Health Care
Richard "Mort" Wasserman, MD, Professor of Pediatrics and Gynecology, College of Medicine, University of Vermont
Jennifer Carbee, Legislative Counsel
Robin Lunge, Legislative Counsel
Wednesday, February 11, 2009
- Committee(s):
- Senate Committee on Finance
- 1:30 p.m.
-
S.48 - An act relating to the marketing of prescribed products
Marjorie Powell, Senior Assistant General Counsel, Pharmaceutical Research Manufacturers of America (PhRMA)
Jessica Wolfe, Manager, State Government Relations, Boston Scientific Corporation
Susan Baker, Health Care Advocate, Vermont Public Interest Research Group
- 2:30 p.m.
-
S.48 - An act relating to the marketing of prescribed products
Testimony via telephone
Christopher White, General Counsel, Advanced Medical Technology Association
- 4:05 p.m.
-
S.48 - An act relating to the marketing of prescribed products
Robin Lunge, Legislative Counsel
Jennifer Carbee, Legislative Counsel
Friday, February 13, 2009
- Committee(s):
- Senate Committee on Finance
- -
-
S.48 - An act relating to the marketing of prescribed products
Andrew MacLean, Lobbyist, Pharmaceutical Research Manufacturers of America (PhRMA)
Ken Libertoff, Director, Vermont Association for Mental Health
Paul Harrington, Executive Vice President, Vermont Medical Society
John Hollar, Lobbyist, GlaxoSmithKline
Jennifer Carbee, Legislative Counsel
Robin Lunge, Legislative Counsel
Wednesday, February 18, 2009
- Committee(s):
- Senate Committee on Finance
- 3:45 p.m.
-
S.48 - An act relating to the marketing of prescribed products
Mark up
Jennifer Carbee, Legislative Counsel
Robin Lunge, Legislative Counsel
Wendy Morgan, Assistant Attorney General, Attorney General's Office
Susan Gretkowski, Lobbyist, Pharmaceutical Research Manufacturers of America (PhRMA)
Thursday, February 19, 2009
- Committee(s):
- Senate Committee on Finance
- 4:00 p.m.
-
S.48 - An act relating to the marketing of prescribed products
Mark up and vote
Wednesday, April 22, 2009
- Committee(s):
- House Committee on Health Care
- 9:00 AM
-
S.48 - An act relating to the marketing of prescribed products
Background presentations
Robin Lunge, Legislative Counsel, Office of Legislative Council
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Rep. Sarah Copeland-Hanzas, House Committee on Health Care
Sen. William H. Carris, Rutland County
Thursday, April 23, 2009
- Committee(s):
- House Committee on Health Care
- 9:00 AM
-
S.48 - An act relating to the marketing of prescribed products
John R Brumsted, Chief Quality Officer, Fletcher Allen Health Care, Vermont Medical Society
Ken Libertoff, Director, Vermont Association for Mental Health
William Sorrell, Vermont Attorney General
- 3:00 PM
-
S.48 - An act relating to the marketing of prescribed products
Catherine Z. Davis, Director of Government Affairs, Lake Champlain Regional Chamber of Commerce
Meredith Jacob, Pharmaceutical Policy Fellow, Washington College of Law
Laura Ziegler, Concerned Citizen
Wendy Morgan, Assistant Attorney General, Attorney General's Office
Robin Lunge, Legislative Counsel, Office of Legislative Council
Friday, April 24, 2009
- Committee(s):
- House Committee on Health Care
- 9:30 AM
-
S.48 - An act relating to the marketing of prescribed products
Robert Emmons MD, Psychiatrist
- After budget meeting
-
S.48 - An act relating to the marketing of prescribed products
Kirke McVay, Psychologist
- 1:15 PM
-
S.48 - An act relating to the marketing of prescribed products
The House recessed this AM and is reconvening at 1:00 PM. So this afternoon's testimony times are now tentative.
Marjorie Powell, Senior Assistant General Counsel, Pharmaceutical Research Manufacturers of America (PhRMA)
David Goggin, Director of State Government Affairs at AmGen, New England Bio-Tech Association
Ann Rugg, Deputy Director, Office of Vermont Health Access
George Dunston, Co-Founder, Obsidian HDS
Tuesday, April 28, 2009
- Committee(s):
- House Committee on Health Care
- 9:00 AM
-
S.48 - An act relating to the marketing of prescribed products
Susan Baker, Health Care Advocate, Vermont Public Interest Research Group
Lila Richardson, Staff Attorney, Office of Vermont Health Care Ombusdman
- 3:00 PM
-
S.48 - An act relating to the marketing of prescribed products
Jessica Wolfe, Manager, State Government Relations, Boston Scientific Corporation
Philene Taormina, Director of Advocacy, AARP
Thomas Tremblay, Associate Vice President for Government Relations, AdvaMed, durable medical equipment
Jonathan Weker, Dr., Vermont Psychiatric Association
Rich Harvie, Owner, Montpelier Pharmacy
Wednesday, April 29, 2009
- Committee(s):
- House Committee on Health Care
- 8:30 AM
-
S.48 - An act relating to the marketing of prescribed products
(Marcia Hams via phone)
Tom Simpatico, MD, Vermont Psychiatric Association
Rep. George W. Till, Jericho
Marcia Hams, Director of Prescription Access and Quality, Community Catalyst
- After Adj.
-
S.48 - An act relating to the marketing of prescribed products
Committee discussion and bill draft mark-up
Robin Lunge, Legislative Counsel, Office of Legislative Council
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Thursday, April 30, 2009
- Committee(s):
- House Committee on Health Care
- 8:30 AM
-
S.48 - An act relating to the marketing of prescribed products
Several witnesses via phone
Harry Chen, Consultant, Health Care Reform Commission
Judy Zsoldos RN
Kara Strempek, Pharmaceutical representative
Robin Lunge, Legislative Counsel, Office of Legislative Council
- After Adj.
-
S.48 - An act relating to the marketing of prescribed products
Committee discussion and bill mark-up
Robin Lunge, Legislative Counsel, Office of Legislative Council
Paul Harrington, Executive Vice-President, Vermont Medical Society
Ken Libertoff, Director, Vermont Association for Mental Health
Hunt Blair, Assistant Director of Health Care Reform, Office of Vermont Health Access
Jim Hester, Director, Commission on Health Care Reform
Friday, May 1, 2009
- Committee(s):
- House Committee on Appropriations
- 9:00 AM
-
S.48 - An act relating to the marketing of prescribed products
Rep. Sarah Copeland-Hanzas, Reporter, House Committee on Health Care
Friday, May 1, 2009
- Committee(s):
- House Committee on Ways and Means
- 1:15 PM
-
S.48 - An act relating to the marketing of prescribed products
Rep. Sarah Copeland-Hanzas, Reporter, House Committee on Health Care
Rep. Steven Maier, Chair, House Committee on Health Care
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Wendy Morgan, Assistant Attorney General, Attorney General's Office
- 3:30 PM
-
S.48 - An act relating to the marketing of prescribed products
Vote
Robin Lunge, Legislative Counsel, Office of Legislative Council
Rep. Sarah Copeland-Hanzas, Reporter, House Committee on Health Care
Rep. Suzi Wizowaty, House Committee on Health Care
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Monday, May 4, 2009
- Committee(s):
- House Committee on Health Care
- 3:00 PM
-
S.48 - An act relating to the marketing of prescribed products
This meeting is Joint with House Corrections and Institutions, and will be in Room 10. Topic: 340(b) drug pricing in Dept. of Corrections
Hunt Blair, Assistant Director of Health Care Reform, Office of Vermont Health Access
Delores Burroughs-Biron MD, Health Services Director, Department of Corrections
Tuesday, May 5, 2009
- Committee(s):
- House Committee on Health Care
- 9:15 AM
-
S.48 - An act relating to the marketing of prescribed products
House amendments
Rep. Joe Acinapura
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Wednesday, May 6, 2009
- Committee(s):
- House Committee on Health Care
- 8:30 AM
-
S.48 - An act relating to the marketing of prescribed products
Committee review of amendments to the bill
Rep. Sarah Copeland-Hanzas, House Committee on Health Care
Wendy Morgan, Assistant Attorney General, Attorney General's Office
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Rep. Bob Helm, Fair Haven
Friday, May 8, 2009
- Committee(s):
- Senate Committee on Finance
- 1:00 p.m.
-
S.48 - An act relating to the marketing of prescribed products
Staff review and testimony
Robin Lunge, Legislative Counsel
Jennifer Lorrentz, Nurse Practitioner, Cambridge Family Practice
Michael Scovner, M.D., Poultney
Wendy Morgan, Assistant Attorney General, Attorney General's Office
Rep. George W. Till, Representative, Jericho
Rep. Kurt Wright, Representative, Burlington
Deborah Richter MD, Family Physician
Paul Harrington, Vermont Medical Society
No committee documents found for S.48 in the 2009 - 2010 Legislative Session.
An act relating to the marketing of prescribed products
Witnesses Who Testified
2009 - 2010 Legislative Session
House Committee on Appropriations
- Rep. Sarah Copeland-Hanzas, Reporter, House Committee on Health Care
House Committee on Health Care
- Rep. Joe Acinapura
- Susan Baker, Health Care Advocate, Vermont Public Interest Research Group
- Hunt Blair, Assistant Director of Health Care Reform, Office of Vermont Health Access
- John R Brumsted, Chief Quality Officer, Fletcher Allen Health Care, Vermont Medical Society
- Delores Burroughs-Biron MD, Health Services Director, Department of Corrections
- Jennifer Carbee, Legislative Counsel, Office of Legislative Council
- Sen. William H. Carris, Rutland County
- Harry Chen, Consultant, Health Care Reform Commission
- Rep. Sarah Copeland-Hanzas, House Committee on Health Care
- Catherine Z. Davis, Director of Government Affairs, Lake Champlain Regional Chamber of Commerce
- George Dunston, Co-Founder, Obsidian HDS
- Robert Emmons MD, Psychiatrist
- David Goggin, Director of State Government Affairs at AmGen, New England Bio-Tech Association
- Marcia Hams, Director of Prescription Access and Quality, Community Catalyst
- Paul Harrington, Executive Vice-President, Vermont Medical Society
- Rich Harvie, Owner, Montpelier Pharmacy
- Rep. Bob Helm, Fair Haven
- Jim Hester, Director, Commission on Health Care Reform
- Meredith Jacob, Pharmaceutical Policy Fellow, Washington College of Law
- Ken Libertoff, Director, Vermont Association for Mental Health
- Robin Lunge, Legislative Counsel, Office of Legislative Council
- Kirke McVay, Psychologist
- Wendy Morgan, Assistant Attorney General, Attorney General's Office
- Marjorie Powell, Senior Assistant General Counsel, Pharmaceutical Research Manufacturers of America (PhRMA)
- Lila Richardson, Staff Attorney, Office of Vermont Health Care Ombusdman
- Ann Rugg, Deputy Director, Office of Vermont Health Access
- Tom Simpatico, MD, Vermont Psychiatric Association
- William Sorrell, Vermont Attorney General
- Kara Strempek, Pharmaceutical representative
- Philene Taormina, Director of Advocacy, AARP
- Rep. George W. Till, Jericho
- Thomas Tremblay, Associate Vice President for Government Relations, AdvaMed, durable medical equipment
- Jonathan Weker, Dr., Vermont Psychiatric Association
- Jessica Wolfe, Manager, State Government Relations, Boston Scientific Corporation
- Laura Ziegler, Concerned Citizen
- Judy Zsoldos RN
House Committee on Ways and Means
- Jennifer Carbee, Legislative Counsel, Office of Legislative Council
- Rep. Sarah Copeland-Hanzas, Reporter, House Committee on Health Care
- Robin Lunge, Legislative Counsel, Office of Legislative Council
- Rep. Steven Maier, Chair, House Committee on Health Care
- Wendy Morgan, Assistant Attorney General, Attorney General's Office
- Rep. Suzi Wizowaty, House Committee on Health Care
Senate Committee on Finance
- Bridget Asay, Assistant Attorney General, Attorney General's Office
- Susan Baker, Health Care Advocate, Vermont Public Interest Research Group
- John R Brumsted, MD, Chief Quality Officer, Fletcher Allen Health Care
- Jennifer Carbee, Legislative Counsel
- Susan Gretkowski, Lobbyist, Pharmaceutical Research Manufacturers of America (PhRMA)
- Paul Harrington, Vermont Medical Society
- Paul Harrington, Executive Vice President, Vermont Medical Society
- John Hollar, Lobbyist, GlaxoSmithKline
- Ken Libertoff, Director, Vermont Association for Mental Health
- Jennifer Lorrentz, Nurse Practitioner, Cambridge Family Practice
- Robin Lunge, Legislative Counsel
- Andrew MacLean, Lobbyist, Pharmaceutical Research Manufacturers of America (PhRMA)
- Chip Morgan, Assistant Attorney General, Attorney General's Office
- Wendy Morgan, Assistant Attorney General, Attorney General's Office
- Marjorie Powell, Senior Assistant General Counsel, Pharmaceutical Research Manufacturers of America (PhRMA)
- Deborah Richter MD, Family Physician
- Elaine Erenrich Rosenburg, Director, Asthma and Allergy Foundation of America/New England Chapter
- Ann Rugg, Deputy Director, Office of Vermont Health Access, Agency of Human Services
- Michael Scovner, M.D., Poultney
- Sen. Peter Shumlin, Senate President Pro Tempore, Windham County
- Tom Simpatico, MD, President, Vermont Psychiatric Association
- Philene Taormina, Director of Advocacy, AARP
- Rep. George W. Till, Representative, Jericho
- Sharon Treat, Director, National Legislative Association on Prescription Drug Prices
- Richard "Mort" Wasserman, MD, Professor of Pediatrics and Gynecology, College of Medicine, University of Vermont
- Christopher White, General Counsel, Advanced Medical Technology Association
- Jessica Wolfe, Manager, State Government Relations, Boston Scientific Corporation
- Rep. Kurt Wright, Representative, Burlington
Fiscal notes and materials available on this web page are provided for informational purposes only, and may not comprise all materials received by the Vermont Legislature or the final fiscal information related to a specific bill. The Legislature is not responsible for the accuracy of any information in these materials, and their posting does not constitute approval or endorsement by the Legislature.
No fiscal documents found for S.48 in the 2009 - 2010 Legislative Session.
No committee of conference members found for S.48 in the 2009 - 2010 Legislative Session.
An act relating to the marketing of prescribed products
Committee of Conference Meetings
2009 - 2010 Legislative Session
| Meeting Date | Committee |
|---|
An act relating to the marketing of prescribed products
Committee of Conference Meeting Full List
2009 - 2010 Legislative Session
No committee of conference meeting history found for S.48 in the 2009 - 2010 Legislative Session.
No committee of conference report found for S.48 in the 2009 - 2010 Legislative Session.
Staff & Other Information
- Staff
- Robin Lunge, Legislative Counsel
- Notes
- Taken up for action in the 2009 Special Session. For details please see </B><a href="http://www.leg.state.vt.us/database/status/summary.cfm?Session=2010.1&Bill=S.48">S.48 of the 2009 Special Session</A>
